Current seroprevalence, vaccination and predictive value of liver enzymes for hepatitis B among refugees in Germany;Aktuelle Seroprävalenz, Impfstatus und prädiktiver Wert der Leberenzyme für Hepatitis B bei Flüchtlingen in Deutschland

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 59, Issue 5, 2016, Pages 578-583

  Hampel, Annika ^a   Solbach, Philipp ^b,c   Cornberg, Markus ^b,c   Schmidt, Reinhold E ^b,c   Behrens, Georg M N ^b,c   Jablonka, Alexandra ^b,c  

^a Klinikum Wolfsburg   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Standort Hannover Braunschweig   (Germany)

Author keywords

Asylum seeker; Hepatitis B; Liver enzymes; Refugees; Vaccination

Indexed keywords

AMINOTRANSFERASE; BIOLOGICAL MARKER; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BLOOD; CHILD; ENZYME ASSAY; FEMALE; GERMANY; HEPATITIS B; HUMAN; INFANT; LIVER FUNCTION TEST; MALE; MASS SCREENING; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PREVALENCE; PROCEDURES; PROGNOSIS; REFUGEE; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX RATIO; STATISTICS AND NUMERICAL DATA; UTILIZATION; VACCINATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOMARKERS; CHILD; CHILD, PRESCHOOL; CLINICAL ENZYME TESTS; FEMALE; GERMANY; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; LIVER FUNCTION TESTS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; PROGNOSIS; REFUGEES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; TRANSAMINASES; VACCINATION; YOUNG ADULT;

EID: 84964325366     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-016-2333-8     Document Type: Article

References (23)

1. Bundesamt für Migration und Flüchtlinge (2015) Prognoseschreiben zur Zahl der im Verteilsystem EASY registrierten Personen nach § 44 Abs. 2 AsylVfG, Hannover
2. Bundesamt für Migration und Flüchtlinge (2015) Schlüsselzahlen Asyl 1. Halbjahr 2015
3. Bozorgmehr K, Razum O (2015) Effect of restricting access to health care on health expenditures among asylum-seekers and refugees: A quasi-experimental study in Germany, 1994–2013. PLoS ONE 10:e0131483 doi:10.1371/journal.pone.0131483
4. Poethko-Müller C, Zimmermann R, Hamouda O et al (2013) Die Seroepidemiologie der Hepatitis A, B und C in Deutschland. Bundesgesundheitsblatt Gesundheitsforsch Gesundheitsschutz 56:707–715. doi:10.1007/s00103-013-1673-x
5. Heidrich B, Cetindere A, Beyaz M et al (2014) High prevalence of hepatitis markers in immigrant populations: a prospective screening approach in a real-world setting. Eur J Gastroenterol Hepatol 26:1090–1097. doi:10.1097/MEG.0000000000000164
6. Naghavi M, Wang H, Lozano R et al (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117–171. doi:10.1016/S0140-6736(14)61682-2
7. Schweitzer A, Horn J, Mikolajczyk RT et al (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386:1546–1555. doi:10.1016/S0140-6736(15)61412-X
8. Chironna M, Germinario C, Lopalco PL et al (2003) Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey. Infection 31:70–74. doi:10.1007/s15010-002-3100-3
9. Padovese V, Egidi AM, Melillo TF et al (2014) Prevalence of latent tuberculosis, syphilis, hepatitis B and C among asylum seekers in Malta. J Public Health 36:22–27. doi:10.1093/pubmed/fdt036
10. Köse Ş, Kuzucu L, Gözaydın A et al (2015) Prevalence of hepatitis B and C viruses among asylum seekers in Izmir. J Immigr Minor Heal 17:76–78. doi:10.1007/s10903-013-9876-7
11. Tafuri S, Prato R, Martinelli D et al (2010) Prevalence of Hepatitis B, C, HIV and syphilis markers among refugees in Bari, Italy. BMC Infect Dis 10:213 doi:10.1186/1471-2334-10-213
12. Burgazli KM, Mericliler M, Sen C et al (2014) The prevalence of hepatitis B virus (HBV) among Turkish immigrants in Germany. Eur Rev Med Pharmacol Sci 18:869–874
13. STIKO (2015) Empfehlungen der Ständischen Impfkommission (STIKO) am RKI-Stand:August 2015. Epidemiol Bull. doi:10.17886/EpiBull-2015-001
14. Jablonka A, Solbach P, Nothdorft S et al (2016) Niedrige Seroprävalenz von Syphilis und HIV bei Flüchtlingen in Deutschland im Jahr 2015. Dtsch Medizinische Wochenschrift. (accepted)
15. Cornberg M, Protzer U, Petersen J et al (2011) Aktualisierung der S 3‑Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion. Z Gastroenterol 49:871–930. doi:10.1055/s-0031-1273462
16. Veldhuijzen IK, Toy M, Hahné SJM et al (2010) Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology 138:522–530. doi:10.1053/j.gastro.2009.10.039
17. Wong WWL, Woo G, Jenny Heathcote E et al (2011) Cost effectiveness of screening immigrants for hepatitis B. Liver Int 31:1179–1190. doi:10.1111/j.1478-3231.2011.02559.x
18. Hahné SJM, Veldhuijzen IK, Wiessing L et al (2013) Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis 13:181 doi:10.1186/1471-2334-13-181
19. Muselmani W, Habbal W, Monem F (2014) Prevalence of „anti-HBc alone“ among Syrian blood donors. J Infect Dev Ctries 8:1013–1015. doi:10.3855/jidc.3827
20. World Health Organization (2009) Hepatitis B vaccines: WHO position paper. Wkly Epidemiol Rec 84:405–420. doi:10.1016/j.vaccine.2009.10.110
21. Organization WH (2015) UNICEF estimates of HepB3 coverage. WHO, Genf
22. Organization WH (2015) vaccine-preventable diseases: monitoring system. 2015 global summary. WHO, Genf
23. Grote U, Wildenau G, Behrens G et al (2015) Primärärztliche Versorgung von Flüchtlingen in Deutschland – Erste Daten zu Demographie und Behandlungsanlässen nach Etablierung einer medizinischen Grundversorgung in Zentralen Erstaufnahmen. Anästhesiologie Intensivmed 56:654–660